Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine
Authors
Keywords
-
Journal
Current Opinion in Virology
Volume 62, Issue -, Pages 101347
Publisher
Elsevier BV
Online
2023-08-20
DOI
10.1016/j.coviro.2023.101347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine
- (2023) Jing Zou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters
- (2023) Geraldine Nouailles et al. Nature Microbiology
- Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
- (2023) Chengjin Ye et al. Microbiology Spectrum
- Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
- (2022) Sam Afkhami et al. CELL
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- (2022) Bo Meng et al. NATURE
- Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts
- (2022) Rhia Kundu et al. Nature Communications
- COVID-19 reinfections among naturally infected and vaccinated individuals
- (2022) Sezanur Rahman et al. Scientific Reports
- BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
- (2022) Abbass Darwich et al. EMBO Molecular Medicine
- Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
- (2022) Rahul K. Suryawanshi et al. NATURE
- Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
- (2022) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
- (2022) Joey Ming Er Lim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
- (2022) Cyril Planchais et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination
- (2022) Aloysious Ssemaganda et al. Nature Communications
- Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
- (2022) Jinyi Tang et al. Science Immunology
- Cross-neutralization of Omicron subvariants after heterologous NVX-CoV2373 boosters: Comparison between prior SARS-CoV-2-infected and infection-naive individuals
- (2022) Min Joo Choi et al. JOURNAL OF INFECTION
- How nasal-spray vaccines could change the pandemic
- (2022) Emily Waltz NATURE
- Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
- (2022) Sebastian Havervall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
- (2022) Tianyang Mao et al. SCIENCE
- Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
- (2022) Mohsen Abdoli et al. VIRUS RESEARCH
- SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
- (2022) Kaori Sano et al. Nature Communications
- Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study
- (2022) Seran Hakki et al. Lancet Respiratory Medicine
- Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
- (2022) Haley E. Mudrick et al. Science Advances
- Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tract
- (2022) Kenrie P.Y. Hui et al. EBioMedicine
- Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex
- (2022) Gabriel Dagotto et al. npj Vaccines
- Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
- (2022) Annabel A Powell et al. LANCET INFECTIOUS DISEASES
- Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
- (2022) Chaitanya Kurhade et al. NATURE MEDICINE
- Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
- (2022) Ruth Link-Gelles et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
- (2022) Felicity Liew et al. EBioMedicine
- Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells
- (2022) Marco Künzli et al. Science Immunology
- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response
- (2021) Zengguo Cao et al. Cellular & Molecular Immunology
- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- (2021) Bryan A. Johnson et al. NATURE
- A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
- (2021) Xianwen Zhang et al. CELL
- Engineering SARS-CoV-2 using a reverse genetic system
- (2021) Xuping Xie et al. Nature Protocols
- A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
- (2021) Paul E. Harris et al. Vaccines
- Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
- (2021) Carly G.K. Ziegler et al. CELL
- Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity
- (2021) William E. Matchett et al. JOURNAL OF IMMUNOLOGY
- Breathing, speaking, coughing or sneezing: What drives transmission of SARS‐CoV‐2?
- (2021) V. Stadnytskyi et al. JOURNAL OF INTERNAL MEDICINE
- Mapping the human genetic architecture of COVID-19
- (2021) NATURE
- Scent of a vaccine
- (2021) Frances E. Lund et al. SCIENCE
- Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19
- (2021) James P Bridges et al. THORAX
- SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
- (2021) Janeri Fröberg et al. Nature Communications
- SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
- (2021) Fiona Tea et al. PLOS MEDICINE
- SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19
- (2021) Paul Z Chen et al. eLife
- Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2
- (2021) Clarissa M. Koch et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
- (2021) Emanuele Andreano et al. NATURE
- Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19
- (2021) Anna H. E. Roukens et al. NATURE IMMUNOLOGY
- Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)
- (2021) Jakob Trimpert et al. Science Advances
- Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
- (2021) Runhong Zhou et al. EBioMedicine
- Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
- (2021) Lorenzo Azzi et al. EBioMedicine
- Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA
- (2021) Ji Eun Oh et al. Science Immunology
- Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
- (2021) Alberto Cagigi et al. JCI Insight
- Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
- (2021) Mariapia Guerrieri et al. Vaccines
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19
- (2020) Inga-Marie Schaefer et al. MODERN PATHOLOGY
- Long-term maintenance of lung resident memory T cells is mediated by persistent antigen
- (2020) Ida Uddbäck et al. Mucosal Immunology
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
- (2020) Annika Nelde et al. NATURE IMMUNOLOGY
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection
- (2020) Sang Hyun Ra et al. THORAX
- An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
- (2020) Liqiang Feng et al. Nature Communications
- Evasion of Type I Interferon by SARS-CoV-2
- (2020) Hongjie Xia et al. Cell Reports
- Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection
- (2020) Sang Heui Seo et al. Vaccines
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Location, location, location: Tissue resident memory T cells in mice and humans
- (2019) Peter A. Szabo et al. Science Immunology
- Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children
- (2018) Ursula J Buchholz et al. JOURNAL OF INFECTIOUS DISEASES
- Combination attenuation offers strategy for live-attenuated coronavirus vaccines
- (2018) Vineet D. Menachery et al. JOURNAL OF VIROLOGY
- Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the lung airways and parenchyma
- (2018) Sean R. McMaster et al. Mucosal Immunology
- Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4+ memory T cells that are associated with protection against tuberculosis
- (2018) Manuela Flórido et al. Mucosal Immunology
- The establishment of resident memory B cells in the lung requires local antigen encounter
- (2018) S. Rameeza Allie et al. NATURE IMMUNOLOGY
- Influenza Vaccine Effectiveness in the Community and the Household
- (2013) S. E. Ohmit et al. CLINICAL INFECTIOUS DISEASES
- Lung niches for the generation and maintenance of tissue-resident memory T cells
- (2013) D L Turner et al. Mucosal Immunology
- A vaccine strategy that protects against genital herpes by establishing local memory T cells
- (2012) Haina Shin et al. NATURE
- Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection
- (2011) J. R. Teijaro et al. JOURNAL OF IMMUNOLOGY
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection
- (2010) Taeg S. Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection
- (2010) Jodi McGill et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Magnitude of Local Immunity in the Lungs of Mice Induced by Live Attenuated Influenza Vaccines Is Determined by Local Viral Replication and Induction of Cytokines
- (2010) Y.-F. Lau et al. JOURNAL OF VIROLOGY
- Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs
- (2008) Jodi McGill et al. JOURNAL OF EXPERIMENTAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started